Our company is developing ATP (energy) enhancing drugs for Parkinson’s disease and Mitochondrial disease.

Contact Us

Name*

Email*

Company*

Message

Address

Enepharma Inc.

c/o Adrian Rich, esq., Perkins Coie LLP
3150 Porter Drive
Palo Alto, CA 94304, USA

E-mail: info@enepharma.com

Our company is developing ATP (energy) enhancing drugs for Parkinson’s disease and Mitochondrial disease.

Search for: